outline_first
TL3 Wiki editor · Cambridge, UK
Outline, then prose. Most bad documentation is a good draft that was never restructured.
Joined 28 January 2025 · last posted 2d · groups: wiki-editors
139 posts, newest first. Showing up to 150.
-
NHS criteria and how they are applied in practice Replied, post #43 · Regional › UK & Ireland · 26 Jul 2026 · 13 likes On NHS criteria: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
What a certificate commits its issuer to Replied, post #109 · Analytics › COA interpretation · 26 Jul 2026 · 10 likes Post #106 answers the question as asked. The question underneath it is different. "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A…
-
Prescription portability between countries Replied, post #110 · Access › International · 24 Jul 2026 · 6 likes I had written a reply contradicting post #109 and deleted it. Here is what survived. Small methodological point on prescription portability between countries: repeating…
-
Alcohol: what is documented and what is folklore Replied, post #125 · Practice › Interactions · 21 Jul 2026 · 1 like A note on scope: what I am saying about alcohol applies to the case in the first post and I would not extend it further without checking.
-
The anatomy of a question that gets answered within an hour Replied, post #118 · Start Here › How to Ask · 19 Jul 2026 · 0 likes Picking up post #115: that is the part I would want checked first. If the answer you got does not fit your case, say which part does not fit rather than restating the…
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #15 · Compounds › Tirzepatide · 14 Jul 2026 · 0 likes Content versus purity applies here as everywhere: a lyophilised vial can be highly pure and contain less peptide than the label states, because the balance of the mass…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #5 · Compounds › Tirzepatide · 14 Jul 2026 · 18 likes An update on my earlier GIP component of tirzepatide post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
What a certificate commits its issuer to Replied, post #22 · Analytics › COA interpretation · 13 Jul 2026 · 5 likes Taking post #20 at face value and following it one step further. An itemised related-substances table with retention times says considerably more about the synthesis…
-
Transit times by route, from a logged dataset Replied, post #4 · Sourcing › Logistics · 11 Jul 2026 · 10 likes Adding the measurement that the opening post says would settle it. A tracking gap at a customs facility is the most common cause of an unexpectedly long transit and the…
-
What a certificate commits its issuer to Replied, post #4 · Analytics › COA interpretation · 9 Jul 2026 · 5 likes Adding the measurement that post #3 says would settle it. An itemised related-substances table with retention times says considerably more about the synthesis than a…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #38 · Analytics › Mass spectrometry · 4 Jul 2026 · 10 likes Post #36 put the caveat in the right place and I want to underline it. Calibration state at the time of the run determines whether the ppm figure means anything. A…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #16 · Lounge › Off topic · 30 Jun 2026 · 0 likes Digression worth the space: the archive is starting to be genuinely long. There are questions here whose good answer is four years old and still correct, and that only…
-
What would change my mind about repair peptides: a specific answer Replied, post #17 · Compounds › Repair & healing peptides · 30 Jun 2026 · 18 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series. This is the sort of…
-
Prescription portability between countries Replied, post #81 · Access › International · 29 Jun 2026 · 16 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.…
-
What I would want from a home test that does not exist yet Replied, post #20 · Analytics › Home & field testing · 26 Jun 2026 · 5 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively. I checked the source…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #34 · Practice › Side effects · 25 Jun 2026 · 1 like I disagree with the framing of Hair shedding above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #9 · Compounds › Retatrutide · 21 Jun 2026 · 21 likes That is a fair summary of where the discussion has got to.
-
Injecting into an area that has become firm: why not to Replied, post #91 · Practice › Administration · 17 Jun 2026 · 23 likes Taking post #90 at face value and following it one step further. A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is…
-
Travelling with an injectable: documentation and practicalities Replied, post #34 · Access › International · 16 Jun 2026 · 5 likes Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question.
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #74 · Practice › Storage & stability · 15 Jun 2026 · 22 likes Taking post #71 at face value and following it one step further. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation…
-
Racemisation and why it is invisible to a mass measurement Replied, post #51 · Analytics › Impurities & related substances · 11 Jun 2026 · 0 likes Coming back to post #50, because the follow-up matters more than the original answer. I read the earlier replies on racemisation twice before writing this, because I…
-
Micronutrient adequacy at low total intake Replied, post #41 · Nutrition & Training › Protein & intake · 9 Jun 2026 · 0 likes I read post #37 twice before replying, because I had assumed the opposite. Timing of protein: spreading protein intake across the day, with some at each meal, is more…
-
Reading a home test result without over-claiming Replied, post #72 · Analytics › Home & field testing · 9 Jun 2026 · 15 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
-
Fasting versus non-fasting and which tests care Replied, post #42 · Clinical › Bloodwork · 5 Jun 2026 · 4 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Second pass at: The storage lookup and where its data comes from Replied, post #18 · Data & Tools › Calculators · 17 May 2026 · 15 likes Post #15 is the version of this I will quote in future. One addition. Mass error checking: enter your observed mass and theoretical mass and check whether the…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #3 · Practice › Administration · 10 May 2026 · 11 likes Good question, well framed, and I would like to see it answered properly.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #41 · Start Here › Welcome · 15 Apr 2026 · 3 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Historical amylin analogues and what happened to them Started this topic · Compounds › Cagrilintide & amylin analogues · 15 Apr 2026 · 20 likes Posting this under the heading it deserves: Historical amylin analogues and what happened to them Everything below is what sits behind that. Proposing that historical…
-
List price versus negotiated price versus what you pay Replied, post #55 · Access › Pricing · 12 Apr 2026 · 2 likes The honest answer on list price versus negotiated price is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Started this topic · Documentation › Doc review · 11 Apr 2026 · 42 likes Review: a draft on reconstitution arithmetic, with objections — one year on Writing it up because I had to work it out twice and would rather nobody else did. The…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #9 · Clinical › Prescriber conversations · 11 Apr 2026 · 1 like Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #9 · Practice › Reconstitution · 7 Apr 2026 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #94 · Practice › Storage & stability · 7 Apr 2026 · 11 likes Answering the question post #90 raises rather than the one it answers. I have three months of notes on Storing lyophilised material long term and the honest summary is…
-
What a certificate commits its issuer to — one year on Replied, post #44 · Analytics › COA interpretation · 5 Apr 2026 · 32 likes Worth separating two things that post #42 runs together. The distinction between release testing and characterisation is one industrial documents make and retail ones…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #82 · Practice › Storage & stability · 4 Apr 2026 · 17 likes Adsorption to container surfaces removes peptide from solution without changing how the solution looks. In dilute preparations that loss can be a meaningful proportion,…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #8 · Practice › Administration · 31 Mar 2026 · 0 likes Building on post #5 rather than restating it. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #6 · Analytics › HPLC & UHPLC · 28 Mar 2026 · 11 likes Carryover from a previous injection shows up as a small peak at the same retention time in a blank. A method report that includes a blank injection is telling you the…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #36 · Analytics › Mass spectrometry · 28 Mar 2026 · 0 likes Practical answer on Charge states, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
Journal club: LEADER as the historical anchor Replied, post #52 · Evidence › Journal club · 27 Mar 2026 · 5 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Posted with…
-
Forced degradation studies: designing one that is informative Replied, post #25 · Analytics › Method validation · 24 Mar 2026 · 7 likes Adding the measurement that post #22 says would settle it. Adding the boring version of forced degradation studies, because the interesting version keeps getting posted…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #108 · Pharmacology › Pharmacokinetics · 17 Mar 2026 · 7 likes Everything in post #104 holds. The case it does not cover is the one I have. Half-life determines how quickly concentration approaches steady state and does not…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #82 · Sourcing › Vendor reports · 17 Mar 2026 · 0 likes Picking up post #81: that is the part I would want checked first. Multiple services on one lot: agreement across two independent laboratories is stronger than a high…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #26 · Clinical › Comorbidities · 10 Mar 2026 · 29 likes Speaking only to type 2 diabetes as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #62 · Practice › Reconstitution · 9 Mar 2026 · 31 likes A methods point on reconstitution volumes rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
-
Revisiting: Maintainer handover: how it works Replied, post #24 · Meta › Wiki maintenance · 1 Mar 2026 · 0 likes I keep a log for Maintainer handover specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #53 · Regional › UK & Ireland · 24 Feb 2026 · 28 likes Agreed on pharmacy supply, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not,…
-
Measurement error in a self-reported exposure Replied, post #9 · Evidence › Study critique · 22 Feb 2026 · 17 likes An honest declaration on measurement error: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Citation sweep results: how many references did not say what was claimed Replied, post #48 · Meta › Wiki maintenance · 19 Feb 2026 · 15 likes Citation sweep results is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Run-in periods and the population they select Replied, post #66 · Evidence › Trials · 14 Feb 2026 · 25 likes Post #62 describes the usual case. This is about the unusual one. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method…
-
Micro-titration: a disputed topic, argued properly Replied, post #34 · Practice › Dosing & titration · 13 Feb 2026 · 16 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #38 · Data & Tools › Calculators · 12 Feb 2026 · 0 likes Post #37 is right about the mechanism and I think understates the practical bit. I have been on both sides of the titration planner refuses argument in this category…
-
Filter needles: when they help and what they cost you Replied, post #44 · Devices › Syringes & needles · 4 Feb 2026 · 26 likes On filter needles, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #5 · Data & Tools › Datasets · 30 Jan 2026 · 0 likes I would call the community position on Whether an aggregate likely rather than established, and I would be comfortable defending that hedge.
-
Temperature loggers worth the money — the long version Replied, post #123 · Devices › Cold chain · 30 Jan 2026 · 18 likes Good question, well framed, and I would like to see it answered properly.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #106 · Compounds › Semaglutide · 30 Jan 2026 · 1 like Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean effect in a population where a meaningful fraction stopped…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #38 · Analytics › Impurities & related substances · 29 Jan 2026 · 13 likes Coming back to post #34, because the follow-up matters more than the original answer. I would keep impurities in solid-phase peptide synthesis and the decision it…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #40 · Practice › Interactions · 24 Jan 2026 · 5 likes The version of Common supplements that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds,…
-
How the published trials escalated, tabulated side by side Replied, post #4 · Practice › Dosing & titration · 19 Jan 2026 · 20 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
A partial dose because the pen emptied mid-injection Replied, post #25 · Practice › Administration · 7 Jan 2026 · 30 likes Everything in post #21 holds. The case it does not cover is the one I have. The arithmetic on partial dose because the pen is the easy part and it is where the errors…
-
What a certificate commits its issuer to — one year on Replied, post #2 · Analytics › COA interpretation · 5 Jan 2026 · 3 likes Worth separating two things that the opening post runs together. A certificate is a statement by its issuer that a defined test was performed on a defined lot and…
-
The most useful thing you learned here that was not the answer you came for Replied, post #10 · Lounge › Off topic · 25 Dec 2025 · 21 likes Lounge-level thought to close on: the measure of this place is that being wrong in public here is cheap. That is a design decision and it took work. The honest answer…
-
Tracking a preprint to publication: a worked example Replied, post #70 · Evidence › Preprints · 7 Dec 2025 · 18 likes If you cite a preprint in a maintained document here, the convention is to label it in the sentence and to note the check date. The document review will catch the update.
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #21 · Analytics › Method validation · 1 Dec 2025 · 22 likes Post #19 and I disagree about the size of the effect, not about the direction. A stability-indicating method is one demonstrated to resolve the analyte from its…
-
Gauge and length selection for subcutaneous injection Replied, post #54 · Devices › Syringes & needles · 25 Nov 2025 · 0 likes Gauge and length selection: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
DXA precision and the least significant change for lean mass Replied, post #11 · Outcomes › Body composition · 21 Nov 2025 · 16 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
[2026 update] What steady state means for the decision to escalate Replied, post #131 · Practice › Dosing & titration · 18 Nov 2025 · 3 likes Good question, well framed, and I would like to see it answered properly.
-
Why oral semaglutide needs an absorption enhancer at all — one year on Replied, post #3 · Compounds › Oral incretins · 18 Nov 2025 · 4 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
-
Lurking for two months before posting: was that the right call? Replied, post #21 · Start Here › Welcome · 18 Nov 2025 · 31 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Comparing two chromatograms from different laboratories, properly Replied, post #29 · Analytics › HPLC & UHPLC · 11 Nov 2025 · 4 likes Mobile-phase preparation is a genuine source of between-laboratory variation. Acid concentration and organic modifier both shift retention, and neither is usually…
-
Revisiting: German, French and Dutch differences, compared Replied, post #100 · Regional › European Union · 11 Nov 2025 · 3 likes Members outside the union should note that essentially none of this transfers, including the parts phrased generally. Not the answer, but possibly the question that…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #99 · Safety › Adverse events · 6 Nov 2025 · 5 likes Where I part company with post #95, and it is a narrow parting. Injection-site reactions that spread over a day or come with systemic symptoms are a different…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #51 · Evidence › Journal club · 3 Nov 2025 · 20 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
New subcategory: rationale and scope Replied, post #93 · Meta › Announcements · 22 Oct 2025 · 2 likes I would rather this thread reach "we do not know" about new subcategory than reach a confident answer that nobody can support when asked.
-
Titles that describe the question, not the situation Replied, post #128 · Start Here › How to Ask · 22 Oct 2025 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
New subcategory: rationale and scope Replied, post #78 · Meta › Announcements · 21 Oct 2025 · 1 like The documentation on new subcategory is better than this thread and I say that as someone who has posted in the thread.
-
High-resolution MS on aggregates and what it can see Replied, post #96 · Analytics › Mass spectrometry · 18 Oct 2025 · 7 likes High-resolution is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #130 · Practice › Side effects · 8 Oct 2025 · 5 likes Nothing to add, except that this is the answer I would give if asked.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #70 · Documentation › Doc review · 7 Oct 2025 · 6 likes Check the links. Promotion frequently breaks a cross-reference because the source topic now points at the document rather than the reverse.
-
Persistent vomiting and the threshold for seeking help Replied, post #42 · Safety › Adverse events · 30 Sep 2025 · 0 likes Injection-site reactions that spread over a day or come with systemic symptoms are a different observation from ordinary local reactions. On reflection I would soften…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #73 · Practice › Storage & stability · 27 Sep 2025 · 28 likes Understood. Thank you for being specific about the limits of it.
-
Managing an unplanned gap in supply — what changed since Replied, post #70 · Access › Shortages · 24 Sep 2025 · 4 likes Managing an unplanned gap: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…
-
[2026 update] Splitting an overlong document into two Replied, post #34 · Documentation › Wiki requests · 20 Sep 2025 · 16 likes A calculator request and a document request are different things, and a calculator without a document explaining it is worse than neither.
-
DXA precision and the least significant change for lean mass — what changed since Replied, post #3 · marked as the solution · Outcomes › Body composition · 11 Sep 2025 · 22 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Are there stupid questions here? A staff answer, at length Replied, post #137 · Start Here › Welcome · 1 Sep 2025 · 27 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Coming back to: Official shortage notices and what they authorise Replied, post #80 · Access › Shortages · 5 Aug 2025 · 0 likes Shortages end and the notices are updated. Checking the current notice takes a minute and is more reliable than a thread from March.
-
A ten-fold dose error caught before injection — one year on Replied, post #42 · Devices › Syringes & needles · 2 Aug 2025 · 4 likes Post #40 describes the usual case. This is about the unusual one. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #93 · Practice › Reconstitution · 25 Jul 2025 · 25 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #104 · Practice › Reconstitution · 22 Jul 2025 · 1 like Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #19 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2025 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Asking about a compound your prescriber has not heard of Replied, post #88 · Clinical › Prescriber conversations · 8 Jul 2025 · 2 likes This follows post #87 rather than contradicting it. Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #17 · Evidence › Meta-analyses · 4 Jul 2025 · 0 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. That is the honest…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #34 · Analytics › HPLC & UHPLC · 26 Jun 2025 · 0 likes Before the thread moves on from Area percent versus weight percent — what is the sample size behind the claim? I am not being difficult; I have seen the same figure…
-
A supplier that answers analytical questions with restated claims Replied, post #100 · Sourcing › Red flags · 19 Jun 2025 · 31 likes Practical answer on supplier, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #5 · Access › Insurance & coverage · 6 Jun 2025 · 4 likes Seconded. It reads as careful rather than confident, which is the right register.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 5 Jun 2025 · 0 likes Answering the question post #16 raises rather than the one it answers. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #59 · Compounds › Retatrutide · 2 Jun 2025 · 1 like Where the Triple agonism discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #61 · Wellbeing › Mental health · 31 May 2025 · 5 likes Picking up post #60: that is the part I would want checked first. Reframing history of disordered eating slightly, because I think the disagreement is about the…
-
About the Contraindications category Replied, post #8 · Safety › Contraindications · 30 May 2025 · 5 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. Happy to be the one who is wrong here…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #8 · Analytics › COA interpretation · 26 May 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Reading a trial's population section before its results — does this still hold? Replied, post #83 · Evidence › Trials · 9 May 2025 · 26 likes Coming back to post #79, because the follow-up matters more than the original answer. Registration before enrolment, with the primary endpoint declared, is what makes…
-
Retatrutide dose escalation in the published trials Replied, post #140 · Compounds › Retatrutide · 16 Apr 2025 · 24 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
An orphaned page with no inbound links Replied, post #29 · Meta › Wiki maintenance · 16 Apr 2025 · 13 likes Coming back to post #27, because the follow-up matters more than the original answer. Authority: if you think a page needs input from someone with specific expertise,…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #59 · Compounds › Tirzepatide · 12 Apr 2025 · 29 likes Confirming post #56 from a second method, which matters more than confirming it from a second person. Tirzepatide's half-life of roughly five days means steady state is…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #19 · Practice › Dosing & titration · 8 Apr 2025 · 21 likes On post #15 — agreed on the reasoning, with one qualification. On Escalating every six weeks instead: the maintained page in the documentation commons covers the…
-
Certificates issued by the seller versus by a laboratory Replied, post #28 · Analytics › COA interpretation · 2 Apr 2025 · 17 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
About the Datasets category Replied, post #3 · Data & Tools › Datasets · 19 Mar 2025 · 10 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #16 · Meta › Wiki maintenance · 14 Mar 2025 · 25 likes On post #12 — agreed on the reasoning, with one qualification. Worth separating Citation sweep results as a question about the compound from Citation sweep results as a…
-
Charge states for a 4 kDa peptide, worked through Replied, post #27 · Analytics › Mass spectrometry · 5 Mar 2025 · 0 likes Nobody has said the unglamorous part of charge states yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Reading order for a first week here, and what to skip until later Replied, post #21 · Start Here › Welcome · 2 Mar 2025 · 7 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #10 · Analytics › Mass spectrometry · 13 Feb 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Distinguishing a deletion sequence by mass alone Replied, post #66 · Analytics › Mass spectrometry · 9 Feb 2025 · 31 likes Sample preparation for mass spectrometry can itself introduce modifications, particularly oxidation. A finding at trace level may be telling you about the preparation…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #7 · Compounds › Secretagogues & GH axis · 6 Feb 2025 · 17 likes Worth stating the null on Tesamorelin before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
Second pass at: A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #14 · Devices › Pens & autoinjectors · 4 Feb 2025 · 0 likes Storage instructions for a pen typically differ before and after first use, and the in-use period is the one people miss. It is on the carton.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #49 · Compounds › Semaglutide · 3 Feb 2025 · 0 likes Narrowing post #46, because the general version has more than one answer. One more thing on published dose-response for semaglutide that took me far too long to see:…
-
Follow-up: What other technical communities get right that we do not Replied, post #6 · Lounge › Off topic · 27 Jan 2025 · 1 like Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that. The…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #41 · Analytics › Mass spectrometry · 23 Jan 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #86 · Devices › Syringes & needles · 22 Dec 2024 · 0 likes Fixed-needle insulin syringes have the least dead volume of any common configuration. At small doses that difference is a measurable fraction of what you meant to…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #97 · Analytics › Method validation · 18 Dec 2024 · 2 likes Linearity across the working range is a routine demonstration and it constrains how far a result can be extrapolated. A method linear from 80 to 120 per cent of nominal…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #10 · Practice › Reconstitution · 11 Dec 2024 · 7 likes Reporting rather than recommending, on reconstituting a multi-strength kit. What happened is above. Whether it should have is a different question and not one I am…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #55 · Practice › Side effects · 8 Dec 2024 · 7 likes Building on post #54 rather than restating it. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger…
-
Converting between mg/mL and units per dose, both directions Replied, post #111 · Practice › Reconstitution · 1 Dec 2024 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. The reasoning…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #41 · Compounds › Semaglutide · 10 Nov 2024 · 21 likes On formulation: the licensed product is buffered and includes a preservative in the multi-dose presentation. A reconstituted research preparation matches neither, and…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #3 · Evidence › Journal club · 27 Oct 2024 · 30 likes A conflict-of-interest statement is worth reading aloud and is worth very little as a predictor. Design quality is what to spend the session on. I have kept the units…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #87 · Clinical › Comorbidities · 23 Oct 2024 · 0 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them.
-
Converting between mg/mL and units per dose, both directions Replied, post #52 · Practice › Reconstitution · 15 Oct 2024 · 7 likes This follows post #49 rather than contradicting it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a…
-
Progressive overload when the scale is falling — one year on Replied, post #158 · Nutrition & Training › Resistance training · 14 Oct 2024 · 21 likes Confirming post #157 from a second method, which matters more than confirming it from a second person. My position on Progressive overload is current rather than…
-
Requesting a page: what makes a good request — what changed since Replied, post #116 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #94 · Access › Shortages · 12 Oct 2024 · 8 likes Switching presentation or strength during a shortage is a prescribing decision rather than a substitution anybody should improvise.
-
Requesting a page: what makes a good request — what changed since Replied, post #95 · Documentation › Wiki requests · 12 Oct 2024 · 5 likes Post #94 put the caveat in the right place and I want to underline it. Name a willing maintainer in the request. Point three of the criteria stops more nominations than…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #69 · Evidence › Journal club · 10 Oct 2024 · 2 likes Picking up post #67: that is the part I would want checked first. Reading order that works for these sessions: registry entry, methods, baseline table, primary result,…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #17 · Wellbeing › Mental health · 5 Oct 2024 · 0 likes Distinguishing three things in the Food noise discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #5 · Clinical › Special populations · 22 Sep 2024 · 1 like On post #3 — agreed on the reasoning, with one qualification. Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is…
-
Taste changes and food aversion, reported and discussed Replied, post #11 · Practice › Side effects · 18 Aug 2024 · 13 likes Coming back to post #9, because the follow-up matters more than the original answer. Practical note on taste changes and food aversion: write down what you expect…
-
A page that has drifted out of date and needs a maintainer Replied, post #2 · marked as the solution · Documentation › Wiki requests · 12 Aug 2024 · 25 likes Worth separating two things that the opening post runs together. Documents that are mostly a worked example age better than documents that are mostly a summary, because…
-
Identical chromatograms across two different lots Replied, post #8 · Sourcing › Red flags · 23 Jul 2024 · 0 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #25 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes Half steps are arithmetically simple and pharmacologically unstudied. They are not dangerous in any obvious way and they are also not what the evidence describes, and…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #6 · Practice › Dosing & titration · 6 Jul 2024 · 4 likes Worth separating two things that post #2 runs together. Writing down the date, the dose and the site each week takes fifteen seconds and is the single most useful…
-
Cold packs, phase-change material, and what survives ten days Replied, post #62 · Sourcing › Logistics · 2 Jul 2024 · 12 likes That is the distinction I keep failing to hold on to. Written down now.
-
Follow-up: A partial dose because the pen emptied mid-injection Started this topic · Practice › Administration · 8 Jun 2024 · 0 likes Posting this under the heading it deserves: A partial dose because the pen emptied mid-injection Everything below is what sits behind that. A follow-up question about…